Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
JDP Therapeutics
JDP Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Quzyttir
Cetirizine
2019-10-04
2030-2032
Allergic rhinitis perennial
,
Urticaria
,
Sinusitis
,
Asthma
,
Common cold
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Cetirizine
healthy volunteers/patients
Nepidermin
laron syndrome
,
pituitary dwarfism
,
glioblastoma
,
breast neoplasms
,
mucinous adenocarcinoma
,
ductal carcinoma breast
,
inflammatory breast neoplasms
,
parkinson disease
,
promyelocytic leukemia acute
,
carcinoma
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
progressive supranuclear palsy
,
paralysis
Sominex
renal cell carcinoma
,
carcinoma
,
kidney neoplasms
,
overweight
,
hypertension
,
left ventricular hypertrophy
,
hypertrophy
,
kidney diseases
,
systolic murmurs
,
isolated systolic hypertension
,
type 2 diabetes mellitus
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use